Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine programs. The tech, called Matrix-M, is designed to trigger an immune ...
After a tense day of confusion and backroom negotiations, the Trump administration moved Wednesday night to restore roughly $2 billion in federal grant money for mental health and addiction programs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results